Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs

by
November 5, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Singapore drops pre-departure requirements for travelers, further eases mask rules

Oil faces a ‘serious problem’ by 2024 as production capacity runs out, warns Goldman — here are 3 big oil stocks with yields as high as 4%

British artificial intelligence scientist and entrepreneur Demis Hassabis.

OLI SCARFF | AFP | Getty Images

Google parent company Alphabet has launched a new drug discovery company in the U.K. called Isomorphic Labs.

The company will build on research carried out by London artificial intelligence lab DeepMind, which Google acquired in 2014. While the firm was only officially announced on Thursday, it was incorporated in February, according to a filing with Companies House, the U.K. company registry.

Demis Hassabis, the CEO and co-founder of DeepMind, is also the founder and CEO of Isomorphic Labs. He will remain CEO of DeepMind.

In a blog post, Hassabis described Isomorphic Labs as a commercial venture with a mission to “reimagine the entire drug discovery process from the ground up.”

A spokesperson for Isomorphic Labs stressed that the company is separate from DeepMind and that it has its own dedicated resources. They stopped short, however, of saying how many staff or how much capital it has at its disposal.

“Where relevant, teams from both companies may collaborate, especially in the early days as Isomorphic Labs is hiring its team,” the spokesperson said.

Isomorphic Labs plans to use artificial intelligence software to create new drugs and medicines.

Identifying new drugs is a long, complex trial-and-error process that involves combining lots of different compounds in different ways. Several companies including London’s BenevolentAI and San Francisco’s Atomwise believe that AI can speed up the process.

“We believe that the foundational use of cutting edge computational and AI methods can help scientists take their work to the next level, and massively accelerate the drug discovery process,” wrote Hassabis, a former child chess prodigy with degrees in computer science and cognitive neuroscience from Cambridge and University College London, respectively.

“AI methods will increasingly be used not just for analyzing data, but to also build powerful predictive and generative models of complex biological phenomena,” he added.

Alphabet has several other companies working on health care including Verily, which is developing software for the health care sector, and Calico, which is working on ageing and extending the human life.

DeepMind has also worked on health care, and it used to have its own dedicated DeepMind Health division. However, this was absorbed by Google in 2018 after a controversial deal with Britain’s National Health Service.

Since then, DeepMind has pursued research in other areas of life science and it has made breakthroughs in a field known as protein folding. Last year, the company announced that it had developed an AI system that can accurately predict the structure that proteins will fold into in a matter of days, solving a 50-year-old “grand challenge.”

ShareTweetPin

Related Posts

Singapore drops pre-departure requirements for travelers, further eases mask rules

by
February 9, 2023
0

People gather outside the ArtScience Museum at Marina Bay Sands in Singapore on January 17, 2023. (Photo by Roslan RAHMAN...

Oil faces a ‘serious problem’ by 2024 as production capacity runs out, warns Goldman — here are 3 big oil stocks with yields as high as 4%

by
February 9, 2023
0

S&P 500 4,117.86 -46.14(-1.11%) Dow 30 33,949.01 -207.68(-0.61%) Nasdaq 11,910.52 -203.27(-1.68%) Russell 2000 1,942.60 -30.01(-1.52%) Crude Oil 78.47 0.00(0.00%) Gold...

‘Lithium Batteries Are the New Oil,’ According to Elon Musk — Here Are 2 Stocks to Take Advantage

by
February 9, 2023
0

S&P Futures 4,137.50 +7.00(+0.17%) Dow Futures 34,065.00 +70.00(+0.21%) Nasdaq Futures 12,580.00 +34.75(+0.28%) Russell 2000 Futures 1,953.00 +3.10(+0.16%) Crude Oil 78.57...

Thursday: Unemployment Claims

by
February 9, 2023
0

by Calculated Risk on 2/08/2023 08:12:00 PM Note: Mortgage rates are from MortgageNewsDaily.com and are for top tier scenarios. Thursday:...

Here are Credit Suisse’s favorite stocks for February

by
February 9, 2023
0

Credit Suisse refreshed its "top of the crop" stock picks for February, as the market tries to build on its...

Next Post

Stocks making the biggest moves premarket: Pfizer, Canada Goose, Live Nation and more

Peloton shares collapse as momentum for its at-home fitness equipment slows

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net